跳至主要内容
临床试验/NCT04327934
NCT04327934终止早期 1 期

Mechanisms of Hypertension in Women With Polycystic Ovary Syndrome

Yale University1 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2017年12月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
终止
入组人数
28
试验地点
1
主要终点
Free Plasma Testosterone Levels

研究概览

简要总结

Women with androgen excess polycystic ovary syndrome (AE-PCOS) leads to hypertension.

详细描述

Our scientific premise is that in AE-PCOS women, the androgen-dominant hormonal milieu causes BP increases via sympathetic activation, vasoconstriction and renal sympathetic nervous system activation. Moreover, this androgen-dominant milieu increases BP via activation of the renin-angiotensin system.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Clinical Diagnosis of Polycystic Ovary Syndrome
  • Able to inject study drug
  • Able to swallow pills
  • Diagnosis of Insulin resistance

排除标准

  • Any woman that does not fit the inclusion criteria

研究组 & 干预措施

Healthy Control

Active Comparator

Healthy control participants.

干预措施: GnRH antagonist (Drug)

Healthy Control

Active Comparator

Healthy control participants.

干预措施: GnRH antagonist + MethylTESTOSTERone 5 MG (Drug)

AE-PCOS

Experimental

Participants with AE-PCOS.

干预措施: GnRH antagonist (Drug)

AE-PCOS

Experimental

Participants with AE-PCOS.

干预措施: GnRH antagonist + MethylTESTOSTERone 5 MG (Drug)

结局指标

主要结局

Free Plasma Testosterone Levels

时间窗: Baseline, assessed at 7 days of GnRH, assessed at 16 days GnRH+ 5 days of Testosterone

Concentration of testosterone in blood.

Baroreflex Response to LBNP

时间窗: Baseline, assessed at 7 days of GnRH, assessed at 16 days GnRH+ 5 days of Testosterone

forearm blood flow (ultrasound)/mean arterial pressure as a linear function of lower body negative pressure. This is an important measure of autonomic control of blood pressure. Indicating the the sensitivity of changes in vessel diameter in response to blood pooling (induced by lower body negative pressure).

Renal Response to LBNP

时间窗: Baseline, assessed at 7 days of GnRH, assessed at 16 days GnRH+ 5 days of Testosterone

POST Lower body negative pressure Plasma renin activity

Resting Systolic Blood Pressure

时间窗: Baseline, assessed at 7 days of GnRH, assessed at 16 days GnRH+ 5 days of Testosterone

Blood pressure prior to lower body negative pressure

Renal Responses to LBNP

时间窗: Baseline, assessed at 7 days of GnRH, assessed at 16 days GnRH+ 5 days of Testosterone

PRE lower body negative pressure Plasma renin activity

Final Systolic Blood Pressure

时间窗: Baseline, assessed at 7 days of GnRH, assessed at 16 days GnRH+ 5 days of Testosterone

SBP at the end of lower body negative pressure

Sympathetic Baroreflex

时间窗: Baseline, assessed at 7 days of GnRH, assessed at 16 days GnRH+ 5 days of Testosterone

microneurography, diastolic blood pressure (finipres) This is an important measure of autonomic control of blood pressure. Indicating the the sensitivity of changes in muscle sympathetic nerve activity in response to small changes in blood pressure induced by drug perfusion (modified Oxford).

Resting Sympathetic Activity

时间窗: Baseline, assessed at 7 days of GnRH, assessed at 16 days GnRH+ 5 days of Testosterone

Total sympathetic nerve activity

次要结局

  • Aldosterone(Baseline, assessed at 7 days of GnRH, assessed at 16 days GnRH+ 5 days of Testosterone)
  • Renal Responses(Baseline, assessed at 7 days of GnRH, assessed at 16 days GnRH+ 5 days of Testosterone)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验